Audit tools are provided to support safe and appropriate prescribing practices. These include adaptable templates, letters and patient-facing messages to facilitate both routine medication reviews and targeted audits, such as those for people at higher risk or with renal impairment.
⇩ Appendix 5a: Audit template – General review of gabapentin and pregabalin prescribing 647KB (PDF) |
⇩ Appendix 5b: Example letter – Invitation for general gabapentinoid review 543KB (PDF) |
⇩ Appendix 5c: Example text message – Invitation for general gabapentinoid review 538KB (PDF) |
⇩ Appendix 5d: Audit template – Gabapentin and pregabalin prescribing in adults with renal impairment 642KB (PDF) |
⇩ Appendix 5e: Example letter – Invitation to review (high dose/renal function) 543KB (PDF) |
⇩ Appendix 5f: Example letter – Invitation to review (co-prescribed gabapentin or pregabalin with an opioid, benzodiazepine or Z-drug) 544KB (PDF) |
⇩ Appendix 5g: Social media – Patient messages 640KB (PDF) |